Malassezia folliculitis (fungal acne) treatment with fluconazole
A single oral dose of fluconazole is not supported as an effective regimen for Malassezia folliculitis. Systemic fluconazole has been reported in regimens of 100–200 mg daily for 1–4 weeks. [1]
Evidence for fluconazole dosing (duration required)
- Reported systemic fluconazole treatment for Malassezia folliculitis is 100–200 mg daily for 1–4 weeks. [1]
- In a published clinical case of Malassezia (Pityrosporum) folliculitis confirmed by histopathology, oral fluconazole 100 mg daily was used with rapid improvement and continued treatment for months before tapering. [2]
Practical implication for “single-dose” therapy
- Fluconazole single-dose approaches (for example, regimens used for vaginal candidiasis) are not evidence-based for Malassezia folliculitis. [1]
Treatment framework for systemic therapy
- Systemic antifungal therapy for Malassezia folliculitis is typically combined with topical antifungal therapy or used as monotherapy in cases of more extensive or recalcitrant disease. [1]
Key evidence supporting non–single-dose systemic azoles
- A 2020 review summarized systemic antifungal regimens used in Malassezia folliculitis, including fluconazole 100–200 mg daily for 1–4 weeks with an approximately 80% clinical effect reported across the cited literature. [1]
Targets and goals of therapy
- The therapeutic goal is clinical clearance of monomorphic pruritic follicular papules and pustules with prevention of recurrence using ongoing topical measures when needed. [1]